Three Seasons Wealth LLC Buys New Shares in Synopsys, Inc. $SNPS

Three Seasons Wealth LLC purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS) during the third quarter, Holdings Channel reports. The fund purchased 1,407 shares of the semiconductor company’s stock, valued at approximately $694,000.

Several other hedge funds have also recently made changes to their positions in SNPS. Lionshead Wealth Management LLC grew its stake in Synopsys by 1.9% during the second quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock worth $469,000 after purchasing an additional 17 shares during the period. YANKCOM Partnership boosted its holdings in shares of Synopsys by 3.3% during the 2nd quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock worth $275,000 after buying an additional 17 shares in the last quarter. Manchester Capital Management LLC grew its position in shares of Synopsys by 5.3% during the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock worth $174,000 after buying an additional 17 shares during the period. Hemington Wealth Management increased its stake in shares of Synopsys by 10.1% in the 2nd quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after acquiring an additional 18 shares in the last quarter. Finally, Concord Asset Management LLC VA lifted its position in shares of Synopsys by 0.8% during the 2nd quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock valued at $1,220,000 after acquiring an additional 18 shares during the period. 85.47% of the stock is owned by institutional investors.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on SNPS shares. Wells Fargo & Company raised their price target on shares of Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a report on Thursday, December 11th. Robert W. Baird reissued a “neutral” rating and set a $535.00 price objective (down previously from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Piper Sandler dropped their price target on Synopsys from $630.00 to $602.00 and set an “overweight” rating on the stock in a research note on Thursday, December 11th. Finally, Needham & Company LLC raised their price objective on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Eleven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $562.13.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $477.14 on Monday. The stock has a market cap of $91.29 billion, a price-to-earnings ratio of 59.72, a PEG ratio of 3.97 and a beta of 1.16. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The firm’s 50-day simple moving average is $437.58 and its 200 day simple moving average is $503.62.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period in the previous year, the company posted $3.40 EPS. The company’s revenue for the quarter was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, research analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.62% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.